These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 22636674)
1. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Valente AJ; Yoshida T; Murthy SN; Sakamuri SS; Katsuyama M; Clark RA; Delafontaine P; Chandrasekar B Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H282-96. PubMed ID: 22636674 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059 [TBL] [Abstract][Full Text] [Related]
3. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4. Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208 [TBL] [Abstract][Full Text] [Related]
4. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. Chandrasekar B; Mummidi S; Mahimainathan L; Patel DN; Bailey SR; Imam SZ; Greene WC; Valente AJ J Biol Chem; 2006 Jun; 281(22):15099-109. PubMed ID: 16554298 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin. Valente AJ; Yoshida T; Izadpanah R; Delafontaine P; Siebenlist U; Chandrasekar B Cell Signal; 2013 Jun; 25(6):1447-56. PubMed ID: 23541442 [TBL] [Abstract][Full Text] [Related]
7. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells. Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903 [TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase attenuates TNFα signaling by reducing Nox1-dependent endosomal ROS production in vascular smooth muscle cells. Choi H; Dikalova A; Stark RJ; Lamb FS Free Radic Biol Med; 2015 Sep; 86():219-27. PubMed ID: 26001727 [TBL] [Abstract][Full Text] [Related]
9. Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo. Doyon P; van Zuylen WJ; Servant MJ Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2850-7. PubMed ID: 24135021 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner. Schreiner CE; Kumerz M; Gesslbauer J; Schachner D; Joa H; Erker T; Atanasov AG; Heiss EH; Dirsch VM Cardiovasc Res; 2011 Apr; 90(1):140-7. PubMed ID: 21071431 [TBL] [Abstract][Full Text] [Related]
12. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation. Bourmoum M; Charles R; Claing A PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355 [TBL] [Abstract][Full Text] [Related]
13. IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-kappaB and AP-1 activation. Cheng G; Wei L; Xiurong W; Xiangzhen L; Shiguang Z; Songbin F Cell Mol Neurobiol; 2009 Dec; 29(8):1161-8. PubMed ID: 19404732 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK. Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545 [TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of Gqα and PLC-β1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1. Atef ME; Anand-Srivastava MB Am J Physiol Cell Physiol; 2014 Jul; 307(1):C97-106. PubMed ID: 24760983 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Li Y; Lévesque LO; Anand-Srivastava MB Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1959-67. PubMed ID: 20852045 [TBL] [Abstract][Full Text] [Related]
18. Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells. Louis S; Saward L; Zahradka P Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H746-56. PubMed ID: 21622819 [TBL] [Abstract][Full Text] [Related]
19. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress. Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB. Ma Y; Zhang L; Peng T; Cheng J; Taneja S; Zhang J; Delafontaine P; Du J Endocrinology; 2006 Mar; 147(3):1256-63. PubMed ID: 16322063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]